Document is current

Any future updates will be listed below

Treatment with nintedanib is as effective and safe in patients with other connective tissue diseases (CTDs)-interstitial lung disease (ILD) as in patients with systemic sclerosis-ILD: A multicenter retrospective study

Crossref DOI link: https://doi.org/10.1007/s10067-025-07323-0

Published Online: 2025-02-07

Published Print: 2025-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark